Bone-Targeting Endogenous Secretory Receptor for Advanced.
The eighteen-month Masters program in Molecular Medicine expands upon the scientific and medical knowledge basis acquired in Bachelor programs and explores in depth the molecular aspects of medicine. Its goal is to train students thoroughly in an area of application of molecular medicine.
Application Period. The application period starts on September 15 and ends on January 15 of the year of enrollment. Online Application. Our online application tool (click to enter) is available for every round of application from September 15 until January 15. When accessing this application tool for the first time you will have to register at.
Therapy, University of North Carolina, Chapel Hill, NC, USA (Prof. H. McLeod). The PhD student T. Paul. will spend about one year of his PhD studies in Chapel Hill and the remaining time in Ulm. 73. Dr Oleg Lunof started his PhD in April 2009 and, of Pharmacology of Natural Products and Clinical Pharmacology in August 2011, he was awarded.
Widespread expression of erythropoietin receptor in brain and its induction by injury. Christoph Ott MSc. 1, Henrik Martens PhD. 2, Imam Hassouna PhD.
The PhD program emphasizes independent research carried out by the students. Doctoral students select three faculty members as their doctoral committee, who closely monitors progress and advises the students with regard to their research project.
Programme Structure. The research and teaching activities in the program are dedicated to the molecular analysis of brain function. The selection of the faculty - with experts in biochemistry, structural biology, cell biology and imaging, in yeast, fly, worm, and mouse genetics, in electrophysiology, and in morphology - and the teaching and research topics reflect the commitment to a.
The PhD project aims to understand early changes in synaptic protein synthesis in a mouse model of dementia in Parkinson's disease. We aim to identify presynaptic changes in the regulation of protein production that alter synaptic function due to the aggregation of the synaptic protein a-synuclein. We intend to discover new synaptic targets for a preventive therapeutical intervention in order.
The Cellular and Molecular Medicine programme offered by the University of Bristol focuses on translational research, in other words turning basic scientific discoveries into something that is clinically useful. Key successes of this type include the development of novel drugs, therapies and diagnostic tests, and the implementation of changes to clinical practice. Several members of staff in.
Other posts on the site.
We are looking for a highly motivated PhD student with relevant education in biological sciences, ideally in the field of cancer research. Based on our previous research and in cooperation with the Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG) Dresden, successful PhD candidates will utilize state-of-the-art technologies.
Translator. Translate texts with the world's best machine translation technology, developed by the creators of Linguee. Linguee. Look up words and phrases in comprehensive, reliable bilingual dictionaries and search through billions of online translations.
Application The Master Program in Molecular Medicine starts in October of each year. Application for October 2019 is no longer possible, since the application deadline has ended. To be considered for the Master Program starting in October 2020, applications need to be submitted between 1 st of December 2019 until 30 th of May 2020. If you want to take part in the study programm, please.
The research was funded by the PhD program Molecular Medicine (MOLMED) of the Medical University of Graz, Nikon Austria within the Nikon-Center of Excellence, Graz, the FWF (Austrian Science Fund: P28529-B27 to R.M.), the doctoral program Metabolic and Cardiovascular Disease ( DK-W1226 ), and P27070. The Nikon Center of Excellence, Graz, is.
Vincent Pieribone attended New York University College of Arts and Sciences where he received a baccalaureate degree in Biology and Chemistry in 1986. He then attend New York University's Graduate School of Arts and Sciences and received his doctorate in Philosophy in 1992 in neuroanatomy and neurophysiology. From 1990.
Mike-Andrew Westhoff, PhD Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm Valerie Bezler Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm Molecular Medicine is a discipline that builds a potent bridge between biological theory and applied medicine. In this talk we will explore.
The author wishes to thank the anonymous referees for their suggestions. The author's laboratory is supported by an internal grant from the University Medical Center Goettingen, and by a Research Grant from the Acid Maltase Deficiency Association.
Cecilia M. P. Rodrigues graduated in Pharmaceutical Sciences from the University of Lisbon in 1992, and received her PhD in Biochemistry from the same University in 1996, after PhD training at the University of Cincinnati, OH, USA (supervisor: Kenneth D. R. Setchell, PhD).